Caricamento...
First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans
The availability of direct oral anticoagulants has caused a paradigm shift in the management of thrombosis. Rivaroxaban and apixaban are 2 direct oral anticoagulants whose target specificity is activated factor X (FXa). However, it is still not fully understood if and how xabans impact platelet func...
Salvato in:
| Pubblicato in: | Clin Appl Thromb Hemost |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714725/ https://ncbi.nlm.nih.gov/pubmed/29050502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029617734310 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|